There's currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the disease, these are both costly and may have limited benefit for many patients ...
Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...
Nonoperative treatment, such physical therapy, is the typical approach to treating rotator-cuff tears. However, surgery is considered in certain patients whose rotator-cuff tears don't resolve with ...
Maternal age and NSAID use during the preconception period were associated with a longer time to pregnancy among women with SpA.
New research suggests that certain medications, including antibiotics, antivirals, vaccines, and anti-inflammatory drugs, may ...
Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal ...
COIMBATORE: In the first week of January this year, the union government banned the use of nimesulide, a non-steroidal ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
AbbVie saw fourth-quarter sales handily beat Wall Street's projections as gains from its newer anti-inflammatory drugs helped offset declines from Humira, once its best performing asset. The drugmaker ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals.The drug ...
Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results